Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.
3 reports, 2 independent
Updated Aug 10
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tilray leads the European medical cannabis market and aims to broaden access through a new partnership involving Italy, Portugal, and Poland.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tilray
pharmaceutical and cannabis company
-
Italy
country in southern Europe
-
Portugal
country in Southwestern Europe
-
Poland
country in Central Europe
- G20 talks in Atlanta featured Rubio supporting Poland, while Lavrov and Kallas clashed over narratives, with Middle East conflicts dominating the agenda.
- Accusations of coup d'état sparked public protests, leading to the suspension of Bartłomiej Sochański and Bogdan Święczkowski by the Constitutional Tribunal.
Coverage
Newest first; wire copies grouped- fool.com
- GlobeNewswireTilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance D
- Unknown outlet